Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on oncology, immunology, multiple sclerosis, and rare diseases. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Since 2015, Sanofi and Regeneron have been in a global collaboration agreement dedicated to pursuing a broad, ambitious and long-term vision for immuno-oncology.